Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom Rider

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Patient Education and Counseling|July 24, 2014
Haematology patients and the Internet--the use of on-line health information and the impact on the patient-doctor relationshipTom Rider, Muzaffar Malik, Timothy Chevassut
Best Practice & Research. Clinical Haematology|August 20, 2013
NOACs for thromboprophylaxis in medical patientsAlexander Ander T Cohen, Tom Rider
BMJ (Clinical Research Ed.)|February 22, 2013
Pathological finger fractureTom Rider, Irfan Baig, Charlie Sayer, et al.
British Journal of Haematology|September 28, 2021
Romboutsia-induced bone marrow necrosis at presentation of acute myeloid leukaemiaDale Seviar, Khaing Nyunt, Charlie Sayer, et al.
JAAD Case Reports|July 26, 2023
A patient with widespread firm nontender nodulesWilliam A Wright, Jon Salisbury, David Wright, et al.
Hematological Oncology|October 15, 2013
Molecular detection of BRAF-V600E is superior to flow cytometry for disease evaluation in hairy cell leukaemiaTom Rider, Robert Powell, Rebecca Gover, et al.
Leukemia & Lymphoma|June 8, 2013
DNMT3A mutations at R882 hotspot are only found in major clones of acute myeloid leukemiaKathrin E Bisling, John N Brewin, Andrew P McGovern, et al.
British Journal of Haematology|June 12, 2023
Defective T-cell response to COVID-19 vaccination in acute myeloid leukaemia and myelodysplastic syndromesJustin Loke, Vinit Upasani, Charlotte Gaskell, et al.
Leukemia|August 9, 2023
FLT3 inhibitors as MRD-guided salvage treatment for molecular failure in FLT3 mutated AMLJad Othman, Nicola Potter, Katya Mokretar, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Patient Education and Counseling|July 24, 2014
Haematology patients and the Internet--the use of on-line health information and the impact on the patient-doctor relationshipTom Rider, Muzaffar Malik, Timothy Chevassut
Best Practice & Research. Clinical Haematology|August 20, 2013
NOACs for thromboprophylaxis in medical patientsAlexander Ander T Cohen, Tom Rider
BMJ (Clinical Research Ed.)|February 22, 2013
Pathological finger fractureTom Rider, Irfan Baig, Charlie Sayer, et al.
British Journal of Haematology|September 28, 2021
Romboutsia-induced bone marrow necrosis at presentation of acute myeloid leukaemiaDale Seviar, Khaing Nyunt, Charlie Sayer, et al.
JAAD Case Reports|July 26, 2023
A patient with widespread firm nontender nodulesWilliam A Wright, Jon Salisbury, David Wright, et al.
Hematological Oncology|October 15, 2013
Molecular detection of BRAF-V600E is superior to flow cytometry for disease evaluation in hairy cell leukaemiaTom Rider, Robert Powell, Rebecca Gover, et al.
Leukemia & Lymphoma|June 8, 2013
DNMT3A mutations at R882 hotspot are only found in major clones of acute myeloid leukemiaKathrin E Bisling, John N Brewin, Andrew P McGovern, et al.
British Journal of Haematology|June 12, 2023
Defective T-cell response to COVID-19 vaccination in acute myeloid leukaemia and myelodysplastic syndromesJustin Loke, Vinit Upasani, Charlotte Gaskell, et al.
Leukemia|August 9, 2023
FLT3 inhibitors as MRD-guided salvage treatment for molecular failure in FLT3 mutated AMLJad Othman, Nicola Potter, Katya Mokretar, et al.
Pageof 1